Literature DB >> 5302229

[Congenital toxoplasmosis with atypical detachment and necrosis of the retina, persistence of the primary vitreous body, additional abnormalities and extensive intraocular ectopic hematopoiesis].

B Gloor, R Haller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5302229     DOI: 10.1007/bf00418446

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


× No keyword cloud information.
  41 in total

1.  Ocular toxoplasmosis.

Authors:  M J HOGAN
Journal:  Am J Ophthalmol       Date:  1958-10       Impact factor: 5.258

2.  Congenital toxoplasmosis.

Authors:  A R DEUTSCH; M E HORSLEY
Journal:  Am J Ophthalmol       Date:  1957-03       Impact factor: 5.258

3.  [Enophthalmos in connatal toxoplasmosis].

Authors:  G PETERS; R SEITZ
Journal:  Klin Monbl Augenheilkd Augenarztl Fortbild       Date:  1958

4.  [Rare duplications of the embryonal retina; contribution to the genesis of ablatio falciformis congenital].

Authors:  G BADTKE
Journal:  Albrecht Von Graefes Arch Ophthalmol       Date:  1954

5.  [Histology of the eye in congenital toxoplasmosis].

Authors:  A PILLAT
Journal:  Wien Klin Wochenschr       Date:  1951-09-07       Impact factor: 1.704

6.  Congenital encephalo-ophthalmic dysplasia.

Authors:  A C KRAUSE
Journal:  Arch Ophthal       Date:  1946-10

7.  Cyclopia.

Authors:  S GARTNER
Journal:  Arch Ophthal       Date:  1947-02

8.  [Not Available].

Authors:  C GASSER; E SCHWARZ
Journal:  Helv Paediatr Acta       Date:  1947-08

9.  Ocular pathology in the rubella syndrome.

Authors:  M Boniuk; L E Zimmerman
Journal:  Arch Ophthalmol       Date:  1967-04

10.  [Pseudotumoral malformations of the eye].

Authors:  J Babel
Journal:  Ophthalmologica       Date:  1966       Impact factor: 3.250

View more
  1 in total

1.  Vitreoretinal reactions and persistent hyaloid vessels.

Authors:  F H Stefani; W A Laszczyk
Journal:  Br J Ophthalmol       Date:  1976-12       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.